(Q37903902)

25 August 2017

1 reference

title

Squamous cell carcinoma and precursor lesions: prevention (English)

1 reference

25 August 2017

main subject

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author

Saman Warnakulasuriya

object named as

Saman Warnakulasuriya

series ordinal

1

0 references

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

57

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

38-50

1 reference

Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Mass media interventions for smoking cessation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Nicotine receptor partial agonists for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Oral tobacco cessation with UK resident Bangladeshi women: a community pilot investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Interventions for smokeless tobacco use cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Diagnostic aids in the screening of oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Tobacco smoking and cancer: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Current topics in the epidemiology of oral cavity and oropharyngeal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Clonidine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Global epidemiology of areca nut usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Can we prevent malignancy by treating premalignant lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

13-cis-retinoic acid in the treatment of oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Corticosteroids for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Betel quid without tobacco as a risk factor for oral precancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

A clinical trial of antioxidant supplements in the treatment of oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

A systematic review of medical interventions for oral submucous fibrosis and future research opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Photodynamic therapy in dentistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Individual behavioural counselling for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Long-term supplementation with alpha-tocopherol and beta-carotene and prevalence of oral mucosal lesions in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Critical evaluation of diagnostic aids for the detection of oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Neuropharmacology of addiction and how it informs treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Biomarkers as intermediate end points in chemoprevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Management of potentially malignant disorders: evidence and critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Interventions for treating oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Natural history of potentially malignant oral lesions and conditions: an overview of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Pilot randomized phase II study of celecoxib in oral premalignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Diagnosis and management of alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Effective management of smoking in an oral dysplasia clinic in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

A review of the nonsurgical treatment of oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Chemoprevention of oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

A smoking cessation programme conducted through dental practices in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Physician advice for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Interventions to reduce harm from continued tobacco use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Response of oral leukoplakias to the administration of vitamin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Population tobacco control interventions and their effects on social inequalities in smoking: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Screening for oral cancer: contributing to the debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Causes of oral cancer--an appraisal of controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Nomenclature and classification of potentially malignant disorders of the oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Tobacco, oral cancer, and treatment of dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Areca nut use: an independent risk factor for oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

Areca nut-abuse liability, dependence and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2011.00395.X

10.1111/J.1600-0757.2011.00395.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference